Gå direkt till huvudinnehållet

Sekretion från bröstvårtorna

Senast uppdaterad: Senast reviderad:
Sakkunnig:

  1. Leung AKC, Pacaud D. Diagnosis and management of galactorrhea. Am Fam Physician 2004; 70: 543-54. PubMed  
  2. Golshan M. Nipple discharge. UpToDate, last updated Nov 28, 2016. www.uptodate.com  
  3. Hussain AN, Policarpio C, Vincent MT. Evaluating nipple discharge. Obstet Gynecol Surv 2006; 61:278. PubMed  
  4. Spack NP, Neinstein LS. Galactorrhea. In: Neinstein LS. Adolescent health care: a practical guide. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2002: 1045-51.
  5. Benjamin F. Normal lactation and galactorrhea. Clin Obstet Gynecol 1994; 37: 887-97. PubMed  
  6. Biller BM. Hyperprolactinemia. Int J Fertil Womens Med 1999; 44: 74-7. PubMed  
  7. Regionalt vårdprogram för hypofystumörer Uppsala-Örebro sjukvårdsregion. 2019-09-15 Version: 04 www.cancercentrum.se  
  8. Raber W, Gessl A, Nowotny P, Vierhapper H. Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization. Clin Endocrinol Oxf 2003; 58: 185-91. PubMed  
  9. Falkenberry SS. Nipple discharge. Obstet Gynecol Clin North Am 2002; 29: 21-9. PubMed  
  10. Mah PM, Webster J. Hyperprolactinemia: etiology, diagnosis, and management. Semin Reprod Med 2002; 20: 365-74. PubMed  
  11. Madlon-Kay DJ. 'Witch's milk'. Galactorrhea in the newborn. Am J Dis Child 1986; 140: 252-3. PubMed  
  12. Luciano AA. Clinical presentation of hyperprolactinemia. J Reprod Med 1999; 44(12 suppl): 1085-90.
  13. Nationellt vårdprogram Hypofystumörer, RCC (hämtad 2021-09-20)
  14. Kapcala LP. Galactorrhea and thyrotoxicosis. Arch Intern Med 1984; 144: 2349-50. PubMed  
  15. Yarkony GM, Novick AK, Roth EJ, Kirschner KL, Rayner S, Betts HB. Galactorrhea: a complication of spinal cord injury. Arch Phys Med Rehabil 1992; 73: 878-80. PubMed  
  16. Rajasoorya C. Hyperprolactinaemia and its clinical significance. Singapore Med J 2001; 42: 398-401. PubMed  
  17. Bankowski BJ, Zacur HA. Dopamine agonist therapy for hyperprolactinemia. Clin Obstet Gynecol 2003; 46: 349-62. PubMed  
  18. Morrison C. The significance of nipple discharge: diagnosis and treatment regimes. Lippincotts Prim Care Pract 1998; 2: 129-40. PubMed  
  19. De Luis DA, Becerra A, Lahera M, Botella JI, Valero MA, Varela C. A randomized cross-over study comparing cabergoline and quinagolide in the treatment of hyperprolactinemic patients. J Endocrinol Invest 2000; 23: 428-34. PubMed  
  20. Webster J, Piscitelli G, Polli A, D'Alberton A, Falsetti L, Ferrari C, et al. Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinemia: a placebo controlled, double blind, multicenter study. European Multicentre Cabergoline Dose-finding Study Group. Clin Endocrinol Oxf 1992; 37: 534-41. PubMed  
  21. Rohn RD. Benign galactorrhea/breast discharge in adolescent males probably due to breast self-manipulation. J Adolesc Health Care 1984; 5: 210-2. PubMed  
  22. Alikasifoglu A, Kandemir N, Akalan N, Yordam N. Pituitary adenoma associated with gigantism and hyperprolactinemia. Pediatr Neurosurg 2001; 35: 325-8. PubMed  
  • Anna Nager, med dr och specialist i allmänmedicin, Karolinska institutet

Tidigare sakkunniga

  • Terje Johannessen, professor i allmennmedisin, Trondheim